The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries

INTRODUCTION: Due to favorable antidepressant (AD) efficacy and tolerability, selective-serotonin reuptake inhibitors (SSRIs) are consistently recommended as substances of first choice for the treatment of major depressive disorder (MDD) in international guidelines. However, little is known about th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fugger, Gernot, Bartova, Lucie, Fabbri, Chiara, Fanelli, Giuseppe, Dold, Markus, Swoboda, Marleen Margret Mignon, Kautzky, Alexander, Zohar, Joseph, Souery, Daniel, Mendlewicz, Julien, Montgomery, Stuart, Rujescu, Dan, Serretti, Alessandro, Kasper, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095529/
https://www.ncbi.nlm.nih.gov/pubmed/34989830
http://dx.doi.org/10.1007/s00406-021-01368-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095529/
https://www.ncbi.nlm.nih.gov/pubmed/34989830
http://dx.doi.org/10.1007/s00406-021-01368-3

Ejemplares similares